Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Prognostic Impact of Other Somatic Mutations and Cytogenetic Abnormalities in Patients with NPM1 and/or FLT3-ITD Mutated AML in the Era of FLT3-Inhibitors: Real-Life Data from the Greek AML Registry

Blood (2024) 144 (Supplement 1): 5956.

https://doi.org/10.1182/blood-2024-208119

Published: 2024

Journal Articles

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Blood (2022) 140 (Supplement 1): 12016–12017.

https://doi.org/10.1182/blood-2022-169972

Published: 2022

Journal Articles

Enestpath Leukemic Stem Cell (LSC) Sub-Study: Analyzing Characteristics of LSC-Positive Patients and Impact of Switch from Imatinib to Nilotinib Therapy on LSCs in Patients with Chronic Myeloid Leukemia

Fermin Sanchez-Guijo, MD PhD, Sergio Matarraz, Eleni Plata, Miguel Sagüés, Montserrat Cortes, Irena Preloznik Zupan, Monica Crugnola, MD, Giovanni Caocci, MD, Heather Oakervee, BSc, MBBS, MD MRCP, FRCPath, Tobias Gedde-Dahl, Krzysztof Warzocha, Wieslaw W. Jedrzejczak, Slawomira Kyrcz-Krzemien, MD PhD, Alexander Kiani, Sharon Supekar, AnaRita Ferreira, Seema Shah, Juan Luis Steegmann, Michele Baccarani, MD

Blood (2019) 134 (Supplement_1): 4160.

https://doi.org/10.1182/blood-2019-124710

Published: 2019

Journal Articles

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Blood (2018) 132 (6): 666–670.

https://doi.org/10.1182/blood-2018-02-833608

Published: 2018

Journal Articles

Determination of the Percentage of CML Patients that Achieve Continuous Complete Molecular Response Under Treatment with TKIs and Are Eligible for Participation in a TKI Discontinuation Study

Blood (2011) 118 (21): 4446.

https://doi.org/10.1182/blood.V118.21.4446.4446

Published: 2011

Journal Articles

Liver Transient Elastography (FibroScan) Correlates with Liver Iron Concentration and Reflects Liver Fibrosis In Patients with Sickle Cell Disease

Ersi Voskaridou, Maria Schina, Eleni Plata, Dimitrios Christoulas, Maria Tsalkani, Maria Dimopoulou, Hlectra Dimitrakopoulou, George Mousoulis, Evangelos Terpos

Blood (2010) 116 (21): 1646.

https://doi.org/10.1182/blood.V116.21.1646.1646

Published: 2010

Journal Articles

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Cornelia Bratengeier, Eleni Plata, Despoina Kaliontzi, Wolfgang Woloszczuk, Evangelos Terpos

Blood (2010) 116 (21): 1010.

https://doi.org/10.1182/blood.V116.21.1010.1010

Published: 2010

Journal Articles

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis, Eleni Plata, Konstantinos Varvagiannis, George Stamatopoulos, Klio Sinopoulou, Aggeliki Balassopoulou, Dimitris Loukopoulos, Evangelos Terpos

Blood (2010) 115 (12): 2354–2363.

https://doi.org/10.1182/blood-2009-05-221333

Published: 2010

Journal Articles

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Eleni Plata, Charoula Xirakia, Panayiotis Tsaftaridis, Georgios Boutsikas, Evangelos Terpos

Blood (2009) 114 (22): 2018.

https://doi.org/10.1182/blood.V114.22.2018.2018

Published: 2009

Journal Articles

Treatment with Deferasirox Effectively Decreases Iron Burden in Patients with Sickle Cell Disease and Thalassemia Intermedia.

Ersi Voskaridou, Eleni Plata, Panagiota Stefanitsi, Marousa Douskou, Dimitrios Christoulas, Evangelos Terpos

Blood (2009) 114 (22): 1517.

https://doi.org/10.1182/blood.V114.22.1517.1517

Published: 2009

Journal Articles

Prolonged Administration of Hydroxyurea Reduces Morbidity and Mortality in Adult Patients with Sickle-Cell Syndromes: Long-Term Experience of a Single Center.

Ersi Voskaridou, Antonios Bilalis, Dimitrios Christoulas, Konstantinos Varvagiannis, Kleio Sinopoulou, Eleni Plata, Panagiotis Tsaftaridis, Dimitris Loukopoulos, Evangelos Terpos

Blood (2008) 112 (11): 1445.

https://doi.org/10.1182/blood.V112.11.1445.1445

Published: 2008

Journal Articles

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Ersi Voskaridou, Eleni Plata, Dimitrios Christoulas, Charoula Xirakia, Eleni Stoupa, Konstantinos Varvagiannis, Antonios Bilalis, Athanasios Papatheodorou, Panagiotis Tsaftaridis, Evangelos Terpos

Blood (2008) 112 (11): 3888.

https://doi.org/10.1182/blood.V112.11.3888.3888

Published: 2008

Journal Articles

Zoledronic Acid Increases Bone Mineral Density in Patients with Thalassemia Intermedia-Induced Osteoporosis Regardless of the Incessant Bone Marrow Expansion.

Ersi Voskaridou, Dimitrios Christoulas, Lito Antoniadou, Panagiotis Tsaftaridis, Eleni Plata, Evangelos Terpos

Blood (2007) 110 (11): 3813.

https://doi.org/10.1182/blood.V110.11.3813.3813

Published: 2007

Journal Articles

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Sotirios Sachanas, Maria K. Angelopoulou, Konstantinos Anargyrou, Styliani I. Kokoris, Theodoros P. Vassilakopoulos, Zacharoula I. Galani, Evangelia M. Dimitriadou, Marina P. Siakantaris, Maria N. Dimopoulou, Flora N. Kontopidou, Marie-Christine Kyrtsonis, Eleni Plata, Panayiotis Tsaftaridis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4718.

https://doi.org/10.1182/blood.V108.11.4718.4718

Published: 2006

Journal Articles

Efficacy of Rituximab in Hairy Cell Leukemia.

Styliani I. Kokoris, Maria K. Angelopoulou, Zacharoula I. Galani, Konstantinos Anargyrou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Flora N. Kontopidou, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Panayiotis Tsaftaridis, Eleni Plata, Christina Kalpadakis, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4719.

https://doi.org/10.1182/blood.V108.11.4719.4719

Published: 2006

Journal Articles

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Argyro Papadogiannis, MD, Marie-Cristine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Antonios G. Antoniadis, MD, Christina Kalpadakis, MD, Sotirios Sachanas, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos Pangalis, MD

Blood (2005) 106 (11): 5074.

https://doi.org/10.1182/blood.V106.11.5074.5074

Published: 2005

Journal Articles

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Marie-Christine Kyrtsonis, MD, Sotirios Sachanas, MD, Theodoros P. Vassilakopoulos, MD, Nikoletta Kafassi, MD, Tatiana Tzenou, MD, Argyro Papadogiannis, MD, Christina Kalpadakis, MD, Antonios G. Antoniadis, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5193.

https://doi.org/10.1182/blood.V106.11.5193.5193

Published: 2005

Journal Articles

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Maria N. Dimopoulou, MD, Christina Kalpadakis, MD, Evangelia M. Dimitriadou, MD, Marie-Christine Kyrtsonis, MD, Styliani I. Kokoris, MD, Panagiotis Tsaftaridis, MD, Flora N. Kontopidou, MD, Marina P. Siakantaris, MD, Eleni Plata, MD, Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4800.

https://doi.org/10.1182/blood.V106.11.4800.4800

Published: 2005

Journal Articles

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Tatiana Tzenou, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Styliani I. Kokoris, MD, Theodoros P. Vassilakopoulos, MD, Penelope Korkolopoulou, MD, Antonia Giannakakis, MD, Eleni Plata, MD, Eustratios Patsouris, MD, Andreas Katsambas, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 2643.

https://doi.org/10.1182/blood.V104.11.2643.2643

Published: 2004

NARROW

The Prognostic Impact of Other Somatic Mutations and Cytogenetic Abnormalities in Patients with NPM1 and/or FLT3-ITD Mutated AML in the Era of FLT3-Inhibitors: Real-Life Data from the Greek AML Registry

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Enestpath Leukemic Stem Cell (LSC) Sub-Study: Analyzing Characteristics of LSC-Positive Patients and Impact of Switch from Imatinib to Nilotinib Therapy on LSCs in Patients with Chronic Myeloid Leukemia

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Determination of the Percentage of CML Patients that Achieve Continuous Complete Molecular Response Under Treatment with TKIs and Are Eligible for Participation in a TKI Discontinuation Study

Liver Transient Elastography (FibroScan) Correlates with Liver Iron Concentration and Reflects Liver Fibrosis In Patients with Sickle Cell Disease

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Angiogenic Molecules and Inflammatory Cytokines in Patients with Thalassemia Major and Double Heterozygous HbS/Beta-Thalassemia; the impact of Deferasirox.

Treatment with Deferasirox Effectively Decreases Iron Burden in Patients with Sickle Cell Disease and Thalassemia Intermedia.

Prolonged Administration of Hydroxyurea Reduces Morbidity and Mortality in Adult Patients with Sickle-Cell Syndromes: Long-Term Experience of a Single Center.

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Zoledronic Acid Increases Bone Mineral Density in Patients with Thalassemia Intermedia-Induced Osteoporosis Regardless of the Incessant Bone Marrow Expansion.

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Efficacy of Rituximab in Hairy Cell Leukemia.

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only